Header Logo

Connection

TAO SHEN to Administration, Oral

Back to Details
This is a "connection" page, showing publications TAO SHEN has written about Administration, Oral.
TAO SHEN
Connection Strength
0.043
Administration, Oral
  1. Targeting RET Solvent-Front Mutants with Alkynyl Nicotinamide-Based Inhibitors. Mol Cancer Ther. 2023 06 01; 22(6):717-725.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.